The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics

Transplant International

Volumn 22, Issue 10, 2009, Pages 970-978

  Weismüller, Tobias J ^a   Negm, Ahmed ^a   Becker, Thomas ^a   Barg Hock, Hannelore ^a   Klempnauer, Jürgen ^a   Manns, Michael P ^a   Strassburg, Christian P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

3 Month survival; Cold ischemia time; Liver transplantation; Model for end stage liver disease; Organ allocation

Indexed keywords

CREATININE; UREA;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TREATMENT DURATION; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; COLD ISCHEMIA; CREATININE; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; SURVIVAL RATE; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; UREA;

EID: 69949158912     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00915.x     Document Type: Article

References (37)

1. Strassburg CP, Becker T, Klempnauer J, Manns MP. Liver transplantation: deciding between need and donor allocation. Internist (Berl) 2004 45 : 1233.
2. Weismuller TJ, Prokein J, Becker T, et al. Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008 43 : 736.
3. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001 7 : 567.
4. Boin IF, Leonardi MI, Pinto AO, et al. Liver transplant recipients mortality on the waiting list: long-term comparison to Child-Pugh classification and MELD. Transplant Proc 2004 36 : 920.
5. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004 10 : 7.
6. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003 124 : 91.
7. Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006 12 : 1049.
8. Nagler E, Van Vlierberghe H, Colle I, Troisi R, de Hemptinne B. Impact of MELD on short-term and long-term outcome following liver transplantation: a European perspective. Eur J Gastroenterol Hepatol 2005 17 : 849.
9. Waki K. UNOS Liver Registry: ten year survivals. Clin Transpl 2006 : 29.
10. Young AL, Rajagenashan R, Asthana S, et al. The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom. Transpl Int 2007 20 : 331.
11. Jacob M, Copley LP, Lewsey JD, et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004 10 : 903.
12. Buenadicha AL, Martin LG, Martin EE, et al. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease. Transplant Proc 2005 37 : 3881.
13. Adler M, De Gendt E, Vereerstraeten P, et al. Value of the MELD score for the assessment of pre- and post-liver transplantation survival. Transplant Proc 2005 37 : 2863.
14. Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004 77 : 99.
15. Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, et al. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival? Transpl Int 2006 19 : 275.
16. Habib S, Berk B, Chang CC, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006 12 : 440.
17. Freeman RB Jr. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology 2008 47 : 1052.
18. Ahmad J, Downey KK, Akoad M, Cacciarelli TV. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Liver Transpl 2007 13 : 1564.
19. de la Mata M, Cuende N, Huet J, et al. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience. Transplantation 2006 82 : 1429.
20. Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, et al. Analysis of liver transplantation outcome in patients with MELD Score > or = 30. Transplant Proc 2008 40 : 797.
21. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007 45 : 797.
22. Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 2008 28 : 606.
23. Dellon ES, Galanko JA, Medapalli RK, Russo MW. Impact of dialysis and older age on survival after liver transplantation. Am J Transplant 2006 6 : 2183.
24. Aberg F, Koivusalo AM, Hockerstedt K, Isoniemi H. Renal dysfunction in liver transplant patients: comparing patients transplanted for liver tumor or acute or chronic disease. Transpl Int 2007 20 : 591.
25. Ahmad J, Bryce CL, Cacciarelli T, Roberts MS. Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume. Ann Intern Med 2007 146 : 707.
26. Northup PG, Pruett TL, Stukenborg GJ, Berg CL. Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. Am J Transplant 2006 6 : 2455.
27. Volk ML, Lok AS, Pelletier SJ, Ubel PA, Hayward RA. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology 2008 135 : 1568.
28. Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS. Re-weighting the model for end-stage liver disease score components. Gastroenterology 2008 135 : 1575.
29. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006 130 : 1652.
30. Londono MC, Guevara M, Rimola A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006 130 : 1135.
31. Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther 2005 21 : 169.
32. Sanchez-Perez B, Santoyo J, Fernandez-Aguilar JL, et al. Preoperative factors and models predicting mortality in liver transplantation. Transplant Proc 2005 37 : 1499.
33. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002 36 : 202.
34. Bahra M, Neumann UP, Jacob D, et al. Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C. Transpl Int 2007 20 : 771.
35. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004 10 : S115.
36. Ioannou GN, Perkins JD, Carithers RL Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008 134 : 1342.
37. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 33 : 464.